Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Jason Yongsheng Chan"'
Autor:
Peiyong Guan, Jianfeng Chen, Chengqiang Mo, Tomoya Fukawa, Chao Zhang, Xiuyu Cai, Mei Li, Jing Han Hong, Jason Yongsheng Chan, Cedric Chuan Young Ng, Jing Yi Lee, Suet Far Wong, Wei Liu, Xian Zeng, Peili Wang, Rong Xiao, Vikneswari Rajasegaran, Swe Swe Myint, Abner Ming Sun Lim, Joe Poh Sheng Yeong, Puay Hoon Tan, Choon Kiat Ong, Tao Xu, Yiqing Du, Fan Bai, Xin Yao, Bin Tean Teh, Jing Tan
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 9, Pp 2132-2145 (2024)
Abstract Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its rarity, and lack of preclinical models. T
Externí odkaz:
https://doaj.org/article/26e77e47357b4536980d9f63bd24fbcb
Autor:
Boon Yee Lim, Zexi Guo, Jing Quan Lim, Tun Kiat Ko, Elizabeth Chun Yong Lee, Bavani Kannan, Jing Yi Lee, Abner Herbert Lim, Zhimei Li, Cedric Chuan-Young Ng, Inny Busmanis, Jason Yongsheng Chan
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Extramammary Paget’s disease (EMPD) is a rare cancer that occurs within the epithelium of the skin, arising predominantly in areas with high apocrine gland concentration such as the vulva, scrotum, penis and perianal regions. He
Externí odkaz:
https://doaj.org/article/b048ce1268704ba08739b85c331f348a
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-20 (2024)
Abstract Peripheral T cell lymphoma (PTCL) represents a group of heterogeneous hematological malignancies, which are notoriously challenging to treat and outcomes are typically poor. Over the past two decades, clinical prognostic indices for patient
Externí odkaz:
https://doaj.org/article/d6efa0be3e304d7aaf6ed861f63b9ad8
Autor:
Bernard Ji Guang Chua, Chen Ee Low, Chun En Yau, Ya Hwee Tan, Jianbang Chiang, Esther Wei Yin Chang, Jason Yongsheng Chan, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamed Farid Bin Harunal Rashid, Miriam Tao, Soon Thye Lim, Valerie Shiwen Yang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-19 (2024)
Abstract The use of central nervous system (CNS) prophylaxis for patients with diffuse large B-cell lymphoma (DLBCL) remains controversial. Although uncommon, CNS relapses are invariably fatal in this otherwise curable disease. Accurate identificatio
Externí odkaz:
https://doaj.org/article/fa15e3df52d3405f9819bde075496542
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1601 (2024)
Programmed cell death-1 (PD1) inhibitors, a form of immune checkpoint inhibitor, are efficacious for metastatic melanoma but are associated with cutaneous adverse reactions (CARs). Studies in Europe and North America showed that CARs are associated w
Externí odkaz:
https://doaj.org/article/89e813aecb43462fb052a44b41b13e92
Autor:
Jason Yongsheng Chan
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5113 (2024)
Since the launch of this Special Issue entitled “Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance”, the field of cancer immunotherapy has continued to witness rapid growth in the development of novel agents,
Externí odkaz:
https://doaj.org/article/e6f43d490a1a499fb90d0815cd3cc1ae
Autor:
Jason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, Francesca Lim, Michelle Limei Poon, Anand Jeyasekharan, Kheng Wei Yeoh, Daryl Tan, Georg Lenz, Choon Kiat Ong, Soon Thye Lim
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Diffuse large B-cell lymphoma (DLBCL) represents the commonest subtype of non-Hodgkin lymphoma and encompasses a group of diverse disease entities, each harboring unique molecular and clinico-pathological features. The understanding of the m
Externí odkaz:
https://doaj.org/article/267c944bf41a4e7c9eaee1dd7f218790
Autor:
Ryoichi Matsunuma, Shoko Sato, Jason Yongsheng Chan, Kazuo Kinoshita, Keisei Taku, Kei Yamaguchi, Ryosuke Hayami, Kazumori Arai, Makoto Suzuki, Michiko Tsuneizumi
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 455-464 (2023)
Primary breast angiosarcoma is an extremely rare disease with a poor prognosis. Primary angiosarcoma is distinct from secondary angiosarcoma, which usually occurs in patients who have been previously treated for breast cancer. The low incidence of pr
Externí odkaz:
https://doaj.org/article/01b8dea502f74710824caf4522c58c74
Autor:
Jianfeng Chen, Jing Han Hong, Yulin Huang, Shini Liu, Jiaxin Yin, Peng Deng, Yichen Sun, Zhaoliang Yu, Xian Zeng, Rong Xiao, Jason Yongsheng Chan, Peiyong Guan, Yali Wang, Peili Wang, Lizhen Liu, Shijun Wen, Qiang Yu, Choon Kiat Ong, Bin-Tean Teh, Ying Xiong, Jing Tan
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background Enhancer of zeste homolog 2 (EZH2), the key catalytic subunit of polycomb repressive complex 2 (PRC2), is overexpressed and plays an oncogenic role in various cancers through catalysis-dependent or catalysis-independent pathways.
Externí odkaz:
https://doaj.org/article/b67020e61b6748208cb6b5f34e466c59
Autor:
Yi‐Qi Li, Chun‐Ling Luo, Jia‐Xin Jiang, Shuai He, Yang Liu, Wen‐Xin Yan, Yi Xia, Qian Cui, Ying Huang, Jing Quan Lim, Dachuan Huang, Izzah Nabilah Hussein, Yan Gao, Guo‐Wang Lin, Yi‐Hong Ling, Dong Ma, Yue‐Tong Zhang, Jason Yongsheng Chan, Pan‐Pan Wei, Xiao‐Xiao Wang, Chee Leong Cheng, Jie Xiong, Wei‐Li Zhao, Choon Kiat Ong, Soon Thye Lim, Hui‐Qiang Huang, Rou‐Jun Peng, Jin‐Xin Bei
Publikováno v:
Advanced Science, Vol 10, Iss 36, Pp n/a-n/a (2023)
Abstract Extranodal natural killer/T‐cell lymphoma (NKTCL) is an aggressive type of lymphoma associated with Epstein–Barr virus (EBV) and characterized by heterogeneous tumor behaviors. To better understand the origins of the heterogeneity, this
Externí odkaz:
https://doaj.org/article/0432e8430c2d4a6981f323d78d593726